Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules

Atherosclerosis-predominant vasculopathy is a common complication of diabetes with high morbidity and high mortality, which is ruining the patient's daily life. As is known to all, traditional Chinese medicine (TCM) SHENQI compound and western medicine rosiglitazone play an important role in th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Gao, Hong, Duan, Yuhong, Fu, Xiaoxu, Xie, Hongyan, Liu, Ya, Yuan, Haipo, Zhou, Mingyang, Xie, Chunguang
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283585/
https://ncbi.nlm.nih.gov/pubmed/30521536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0207683
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares